|

Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.

RECRUITINGN/ASponsored by Poitiers University Hospital
Actively Recruiting
PhaseN/A
SponsorPoitiers University Hospital
Started2023-07-20
Est. completion2026-10-20
Eligibility
Age60 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05709210

Summary

This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.

Eligibility

Age: 60 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient consulting in routine care in one of the CMRR
* No sensory impairment that may compromise smartphone use

Exclusion Criteria:

* Inability to perform MMSE or MMSE \< 20 ;
* Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
* Severe anxiety or depressive disorder HADS score ≥ 17
* Terminal phase of a severe disease
* Evidence of a lesion on MRI that may be involved in cognitive impairment

Conditions3

Alzheimer DiseaseAlzheimer's DiseaseMemory Disorders

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.